| For: | Gauss A, Ehehalt R, Lehmann WD, Erben G, Weiss KH, Schaefer Y, Kloeters-Plachky P, Stiehl A, Stremmel W, Sauer P, Gotthardt DN. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis. World J Gastroenterol 2013; 19(33): 5454-5463 [PMID: 24023488 DOI: 10.3748/wjg.v19.i33.5454] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i33/5454.htm |
| Number | Citing Articles |
| 1 |
Hisamitsu Hayashi, Sotaro Naoi, Yu Hirose, Yusuke Matsuzaka, Ken Tanikawa, Koji Igarashi, Hironori Nagasaka, Masayoshi Kage, Ayano Inui, Hiroyuki Kusuhara. Successful treatment with 4‐phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption. Hepatology Research 2016; 46(2) doi: 10.1111/hepr.12561
|
| 2 |
Jesús M. Urman, José M. Herranz, Iker Uriarte, María Rullán, Daniel Oyón, Belén González, Ignacio Fernandez-Urién, Juan Carrascosa, Federico Bolado, Lucía Zabalza, María Arechederra, Gloria Alvarez-Sola, Leticia Colyn, María U. Latasa, Leonor Puchades-Carrasco, Antonio Pineda-Lucena, María J. Iraburu, Marta Iruarrizaga-Lejarreta, Cristina Alonso, Bruno Sangro, Ana Purroy, Isabel Gil, Lorena Carmona, Francisco Javier Cubero, María L. Martínez-Chantar, Jesús M. Banales, Marta R. Romero, Rocio I.R. Macias, Maria J. Monte, Jose J. G. Marín, Juan J. Vila, Fernando J. Corrales, Carmen Berasain, Maite G. Fernández-Barrena, Matías A. Avila. Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach. Cancers 2020; 12(6) doi: 10.3390/cancers12061644
|
| 3 |
Jesus M. Banales, Mercedes Iñarrairaegui, Ander Arbelaiz, Piotr Milkiewicz, Jordi Muntané, Luis Muñoz‐Bellvis, Adelaida La Casta, Luis M. Gonzalez, Enara Arretxe, Cristina Alonso, Ibon Martínez‐Arranz, Ainhoa Lapitz, Alvaro Santos‐Laso, Matias A. Avila, Maria L. Martínez‐Chantar, Luis Bujanda, Jose J.G. Marin, Bruno Sangro, Rocio I.R. Macias. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. Hepatology 2019; 70(2) doi: 10.1002/hep.30319
|
| 4 |
Peter Fickert. Bacteria as key players in primary sclerosing cholangitis?. Gut 2023; 72(4) doi: 10.1136/gutjnl-2022-327876
|
| 5 |
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, Nikoletta Fotaki. Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis. European Journal of Pharmaceutical Sciences 2020; 152 doi: 10.1016/j.ejps.2020.105458
|
| 6 |
Mary Ayers, Silvia Liu, Aatur D. Singhi, Karis Kosar, Pamela Cornuet, Kari Nejak-Bowen. Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-04358-6
|
| 7 |
Wolfgang Bernhard, Christian F. Poets, Axel R. Franz. Choline and choline-related nutrients in regular and preterm infant growth. European Journal of Nutrition 2019; 58(3) doi: 10.1007/s00394-018-1834-7
|
| 8 |
Susanne Heimerl, Alfred Boettcher, Harald Kaul, Gerhard Liebisch. Lipid profiling of lipoprotein X: Implications for dyslipidemia in cholestasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016; 1861(8) doi: 10.1016/j.bbalip.2016.04.016
|
| 9 |
Peter Fickert, Alvin C. Lin, Helmut Ritschl, Niels Hammer, Helmut Denk. Portal venous branches as an anatomic railroad for a gut-bile duct-axis. Journal of Hepatology 2023; 79(2) doi: 10.1016/j.jhep.2023.03.043
|
| 10 |
Shawn A Ritchie, Dushmanthi Jayasinge, Li Wang, Dayan B Goodenowe. Improved specificity of serum phosphatidylcholine detection based on side-chain losses during negative electrospray ionization tandem mass spectrometry. Analytical and Bioanalytical Chemistry 2016; 408(27) doi: 10.1007/s00216-016-9884-2
|
| 11 |
Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou. Bile Acids and Biliary Fibrosis. Cells 2023; 12(5) doi: 10.3390/cells12050792
|
| 12 |
Elisabeth Tatscher, Samy Mady, Peter Fickert. Emerging Targets for the Treatment of Primary Sclerosing Cholangitis. Seminars in Liver Disease 2025; 45(03) doi: 10.1055/a-2601-9426
|
| 13 |
Yoshito Ikeda, Shin-ya Morita, Tomohiro Terada. Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00476-2
|
| 14 |
Nan Chen, Lin-lin Wang, Juan Xue, Xiang-bo Ma, Sheng Zhao, Rui-xue Rong, Hong-quan Li, Liang Ding, Ming-zhi Zheng, Ying-ying Chen, Fei Duan, Yue-liang Shen. Different metabolic profiles of K1 serotype and non-serotype K1 and K2 Klebsiella pneumoniae isolates in oral infection mice model. Microbial Pathogenesis 2014; 75 doi: 10.1016/j.micpath.2014.08.006
|
| 15 |
Ryuta Muraki, Yoshifumi Morita, Shinya Ida, Ryo Kitajima, Satoru Furuhashi, Makoto Takeda, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Yusuke Takanashi, Yasushi Hamaya, Ken Sugimoto, Jun Ito, Kazuhito Kawata, Hideya Kawasaki, Tomohito Sato, Tomoaki Kahyo, Mitsutoshi Setou, Hiroya Takeuchi. Phosphatidylcholine in bile‐derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma. Cancer Medicine 2023; 12(12) doi: 10.1002/cam4.5973
|
| 16 |
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20) doi: 10.3390/cancers15204947
|
| 17 |
L Valestrand, N L Berntsen, F Zheng, E Schrumpf, S H Hansen, T H Karlsen, R S Blumberg, J R Hov, X Jiang, E Melum. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells. Clinical and Experimental Immunology 2021; 203(2) doi: 10.1111/cei.13541
|
| 18 |
Andreas Blesl, Vanessa Stadlbauer. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021; 13(3) doi: 10.3390/nu13031018
|
| 19 |
Peter Fickert, Martin Wagner. Biliary bile acids in hepatobiliary injury – What is the link?. Journal of Hepatology 2017; 67(3) doi: 10.1016/j.jhep.2017.04.026
|
| 20 |
Wolfgang Stremmel, Simone Staffer, Ralf Weiskirchen. Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1. International Journal of Molecular Sciences 2019; 20(16) doi: 10.3390/ijms20164034
|
| 21 |
Kan He, Lining Cai, Qin Shi, Hao Liu, Thomas F. Woolf. Inhibition of MDR3 Activity in Human Hepatocytes by Drugs Associated with Liver Injury. Chemical Research in Toxicology 2015; 28(10) doi: 10.1021/acs.chemrestox.5b00201
|
| 22 |
Jie Zhou, Dagang Zhu, Yixin Xu, Chao Chen, Kun Wang. Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03246-3
|
| 23 |
Wolfgang Bernhard. Lung surfactant: Function and composition in the context of development and respiratory physiology. Annals of Anatomy - Anatomischer Anzeiger 2016; 208 doi: 10.1016/j.aanat.2016.08.003
|
| 24 |
Toshikazu Ohigashi, Keishi Kanno, Akiko Sugiyama, Phuong Thao Nguyen, Nobusuke Kishikawa, Yuichiro Otani, Tomoki Kobayashi, Hiroaki Matsuo, Susumu Tazuma. Protective effect of phosphatidylcholine on lysophosphatidylcholine‐induced cellular senescence in cholangiocyte. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(12) doi: 10.1002/jhbp.684
|
| 25 |
Munirah Alsaleh, Zoe Leftley, Thomas A. Barbera, Larry K. Koomson, Abigail Zabron, Mary M.E. Crossey, Helen L. Reeves, Matthew Cramp, Stephen Ryder, Shaun Greer, Martin Prince, Paiboon Sithithaworn, Mohamed Shariff, Narong Khuntikeo, Watcharin Loilome, Puangrat Yongvanit, Yi-Liang Shen, I. Jane Cox, Roger Williams, Christopher A. Wadsworth, Elaine Holmes, Kathryn Nash, Simon D. Taylor-Robinson. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort. Journal of Clinical and Experimental Hepatology 2020; 10(1) doi: 10.1016/j.jceh.2019.06.001
|
| 26 |
Maria Arechederra, Maite G. Fernandez-Barrena, Carmen Berasain, Matias A. Avila. Mouse models of primary sclerosing cholangitis: we just can’t get enough. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.106
|
| 27 |
Tanja Elger, Muriel Huss, Hauke Christian Tews, Marcus Höring, Johanna Loibl, Arne Kandulski, Martina Müller, Gerhard Liebisch, Christa Buechler. Reciprocal Serum Phosphatidylcholine Signatures Are Related to Intestinal Inflammation in Inflammatory Bowel Disease and Liver Fibrosis in Primary Sclerosing Cholangitis—An Exploratory Study. Biomedicines 2026; 14(7) doi: 10.3390/biomedicines14071485
|
| 28 |
Lorenz Pfleger, Emina Halilbasic, Martin Gajdošík, Diana Benčíková, Marek Chmelík, Thomas Scherer, Siegfried Trattnig, Michael Krebs, Michael Trauner, Martin Krššák. Concentration of Gallbladder Phosphatidylcholine in Cholangiopathies: A Phosphorus‐31 Magnetic Resonance Spectroscopy Pilot Study. Journal of Magnetic Resonance Imaging 2022; 55(2) doi: 10.1002/jmri.27817
|
| 29 |
Rina Shimizu, Keishi Kanno, Akiko Sugiyama, Hiroki Ohata, Anna Araki, Nobusuke Kishikawa, Yasuhiro Kimura, Hiroya Yamamoto, Masanobu Kodama, Kenji Kihira, Susumu Tazuma. Cholangiocyte senescence caused by lysophosphatidylcholine as a potential implication in carcinogenesis. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(9) doi: 10.1002/jhbp.256
|